Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease

By sjmartinez • October 21, 2022

Nee R, Yuan CM, Narva AS, Yan G, Norris KC. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease. Nephrol Dial Transplant. 2022 Oct 20:gfac283. doi: 10.1093/ndt/gfac283. Epub ahead of print. PMID: 36264305.

Tags: cardiovascular disease, Chronic kidney disease, diabetes mellitus, glucagon-like peptide-1 receptor agonist, Nephrology, nonsteroidal mineralocorticoid receptor antagonist, Publications, sodium-glucose cotransporter-2 inhibitor

Artificial intelligence in medicine and nephrology: hope, hype, and reality

Glassock RJ. Artificial intelligence in medicine and nephrology: hope, hype, and reality. Clin Kidney J. 2024 Mar 22;17(4):sfae074. doi: 10.1093/ckj/sfae074. PMID: 38618490; PMCID: PMC11015150.

Prognostic Scoring in IgA Vasculitis

Glassock RJ. Prognostic Scoring in IgA Vasculitis. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):409-411. doi: 10.2215/CJN.0000000000000444. PMID: 38598194.

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant

Bromberg JS, Bunnapradist S, Samaniego-Picota M, Anand S, Stites E, Gauthier P, Demko Z, Prewett A, Armer-Cabral M, Marshall K, Kaur N, Bloom MS, Tabriziani[...]